+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cefuroxime"

Cephalosporin Global Market Report 2024 - Product Thumbnail Image

Cephalosporin Global Market Report 2024

  • Report
  • March 2024
  • 175 Pages
  • Global
From
From
Cephalosporin Markets in China - Product Thumbnail Image

Cephalosporin Markets in China

  • Report
  • October 2023
  • 270 Pages
  • China
From
Cephalosporin Industry Forecasts - China Focus - Product Thumbnail Image

Cephalosporin Industry Forecasts - China Focus

  • Report
  • October 2023
  • 135 Pages
  • China
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Cefuroxime is an antibiotic used to treat a variety of bacterial infections. It belongs to the cephalosporin class of antibiotics, which are used to treat a wide range of infections caused by bacteria. Cefuroxime is effective against a broad range of Gram-positive and Gram-negative bacteria, including Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli. It is also used to treat infections of the urinary tract, skin, and respiratory tract. Cefuroxime is available in both oral and injectable forms. The cefuroxime market is highly competitive, with a number of generic and branded products available. The market is driven by the increasing prevalence of bacterial infections, the growing demand for antibiotics, and the availability of generic cefuroxime. Some of the major companies in the cefuroxime market include Pfizer, GlaxoSmithKline, Merck, Sanofi, and Novartis. Show Less Read more